Home » View latest Atropine Autoinjector Tenders from India

View latest Atropine Autoinjector Tenders from India

TendersOnTime provides latest updates on Indian Atropine Autoinjector Tenders from various state and central government tendering authorities. The information on Atropine Autoinjector online tenders and turnkey projects from India is collected from various sources viz: e procurement tenders list, newspapers and tender bulletin etc.

Country: India

Supply of Atropine Inj Each ml to contain: Atropine 0.6 mg, Qty: 01ml Vial/Amp

TOT Ref No.: 73690920

Deadline: 31 Oct 2024

Country: India

10131, Atropine Point 6 Mg 1 Ml Inj, Atropine Point 6 Mg 1 Ml Inj, Qty: 150 Amp, (BOQ Item #7)

TOT Ref No.: 100238773

Deadline: 10 May 2024

Country: India

Inj Atropine, Qty: 150 Each, (BOQ Item #31)

TOT Ref No.: 100133968

Deadline: 27 Apr 2024

Country: India

Atropine, Qty: 5 DROPS, (BOQ Item #5)

TOT Ref No.: 100270250

Deadline: 11 May 2024

Country: India

Injection Atropine, Qty: 10 Nos, (BOQ Item #92)

TOT Ref No.: 100299834

Deadline: 13 May 2024

Country: India

10131, Atropine Sulphate Zero Point Six Mg 1 Ml Inj, Atropine Sulphate Zero Point Six Mg 1 Ml Inj

TOT Ref No.: 100304142

Deadline: 13 May 2024

Country: India

Supply of Atropine Sulphate Inj. I.P. 0.6 mg/ml-1ml Amp.

TOT Ref No.: 99173036

Deadline: 15 May 2024

Country: India

Inj Atropine, Qty: 7200 Pieces, (BOQ Item #43)

TOT Ref No.: 99607261

Deadline: 25 Apr 2024

Country: India

Atropine Inj, Qty: 20000 AMP, (BOQ Item #28)

TOT Ref No.: 99788865

Deadline: 29 Apr 2024

Country: India

Inj Atropine 1Ml, Qty: 1 EACH, (BOQ Item #19)

TOT Ref No.: 99997131

Deadline: 04 May 2024

Country: {{rowDetails.Country_Name}}

TOT Ref No.: {{rowDetails.ID}}

Deadline: {{rowDetails.Bid_Deadline_1}}

Deadline: {{rowDetails.Bid_Deadline_1}}

No data Found!! Please search again

Browse Tenders

Browse Tenders from below Sections

Call Action

Get A Callback Within 24 Hours

Fill form below to get callback from Tender Experts.

Click button to send your details.